[8], [38], [39], [40] However, few studies have investigated the role of CRP in PLC. (Table S1) [38], [41], [42], [43], [44] The current study, which includes the largest number of patients, demonstrated that an elevated CRP level was associated with clinical tumor status (P = 0.005), clinical nodal status (P = 0.003) and differentiation of tumor cells (P = 0.014) in PLC, which is similar to previous findings with OSCC. [8]. The gene discussed is CRP; the disease is neoplasm.